Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of FOLFOX in Rectal Cancer
NCT01274962Phase 2Completed
- Sponsor
- Jewish General Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in rectal cancer, sponsored by Jewish General Hospital. Started Nov 2009; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01274962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274962.